RP Da Silva, JIB Gonçalves, RF Zanin… - Frontiers in …, 2021 - frontiersin.org
Introduction Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resulting in a range of clinical …
K Lino, GMC Guimarães, LS Alves, AC Oliveira… - The Brazilian Journal of …, 2021 - Elsevier
Introduction Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective To study the association …
Background SARS-CoV-2 infects through the respiratory route and triggers inflammatory response by affecting multiple cell types including type II alveolar epithelial cells. SARS-CoV …
Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may represent disease severity. We aimed to assess plasma inflammatory mediator …
Complement system hyperactivation has been proposed as a potential driver of adverse outcomes in severe acute respiratory syndrome coronavirus 2 infected patients, given prior …
Angiotensin-converting enzyme 2 (ACE2) is a receptor for the spike protein of SARS-COV-2 that allows viral binding and entry and is expressed on the surface of several pulmonary and …
The COVID-19 pandemic caused by SARS-CoV-2 infection has been of unprecedented clinical and socio-economic worldwide relevance. The case fatality rate for COVID-19 grows …
K Nagaoka, H Kawasuji, Y Murai, M Kaneda… - Frontiers in …, 2022 - frontiersin.org
Background The role of type I interferons (IFNs) in the early phase of COVID-19 remains unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID …
Background Severe cases of coronavirus disease 2019 (COVID-19) have increased risk for acute kidney injury (AKI). The exacerbation of the immune response seems to contribute to …